Lu Li

7PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer geneticsChemotherapyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 03, 2024
The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Weiwei Guan, Congyue Zhang, Tongguo Miao

|Jan 23, 2024
Monocyte-to-High-Density Lipoprotein-Cholesterol Ratio Predicts Prognosis of Hepatocellular Carcinoma in Patients with Metabolic-Associated Fatty Liver Disease.

Tongguo Miao, Xianzhe Lou, Shiming Dong

|Nov 07, 2023
GI cancers in lean NAFLD: A journey in the search for evidence.

Lu Li, Zeyu Wang, Yuwu Wu

|Jun 14, 2023
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p.

Lu Li, Rong Ai, Xiwei Yuan

|Nov 21, 2022
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B.

Siyu Zhang, Xiaoxiao Zhang, Huiming Jin

|May 09, 2022
Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study.

Wencong Li, Jing Liang, Jihong An

Pageof 2

Frequent Collaborators

3 joint publications

Dandan Zhao

3 joint publications

Rong Ai

3 joint publications

Yuemin Nan

2 joint publications

Xiaoxiao Zhang